Skip to main content
Clinical Trials/IRCT20091027002639N21
IRCT20091027002639N21
Recruiting
Phase 2

Clinical trial of evaluation of effectiveness and clinical side effects of levetiracetam and topiramate in control of seizures of oral prednisolone refractory infantile spasms

Yazd University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Yazd University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yazd University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Age range of 2 months\-1 year
  • Having infantile spasms based on definition of the International League Against Epilepsy
  • Resistance of their seizure to treatment of 2 mg/kg/day prednisolone for two months
  • Not used of other antiepileptic drugs

Exclusion Criteria

  • Discontinuation of levetiracetam and topiramate usage for more than one week
  • Allergy to levetiracetam and topiramate
  • Irregular drugs usage
  • Not returning for follow up

Outcomes

Primary Outcomes

Not specified

Similar Trials